Combining papillary and tubular adenocarcinoma as predictors, the positive predictive value (PPV) for HER-2 positivity was calculated to be 88%, indicating a high probability that HER-2 positive cases correspond to these histological subtypes. This evidence concerns the gene ERBB2 and tubular adenocarcinoma.